Predictors of chemotherapy patients' intentions to engage in medical error prevention.
BACKGROUND
Patients can make contributions to the safety of chemotherapy administration but little is known about their motivations to participate in safety-enhancing strategies. The theory of planned behavior was applied to analyze attitudes, norms, behavioral control, and chemotherapy patients' intentions to participate in medical error prevention.


METHODS
A quantitative, cross-sectional survey study among chemotherapy patients treated at the oncology/hematology department of a large regional hospital was conducted. Confirmatory factor analysis and structural equation modeling were used to investigate the relationship between patients' responses to measures of attitudes, norms, and behavioral control and their intentions.


RESULTS
Four hundred seventy-nine patients completed the survey (52% response rate). Attitudes, perceived behavioral control, and subjective norms explained 62% of the variance in intentions to engage in error monitoring and reporting. Perceived behavioral control (beta = 0.476), norms relating to patients' relatives (beta = 0.343), and instrumental attitudes (beta = 0.281) were the strongest (direct) predictors of patients' intentions. Experiential attitudes had the smallest effect on intentions (beta = 0.178). Subjective norms relating to expectations attributed to oncology staff had strong direct and indirect effects on patients' intentions (total effect, 0.382).


CONCLUSIONS
Patients acknowledge the benefit of error monitoring and reporting and anticipate positive outcomes of involvement, but their valuations of the process of engaging in error prevention are less positive. Behavioral control and perceptions of staff approval are central for patients. Involvement of cancer patients in safety requires oncologists to address their patients' normative and control beliefs through education and proactive approval of patient engagement.
Schwappach
David L B
DL
Swiss Patient Safety Foundation, Asylstr. 77, 8032 Zuerich, Switzerland. schwappach@patientensicherheit.ch
Wernli
Martin
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003430:Cross-Sectional Studies; D003625:Data Collection; D005260:Female; D006801:Humans; D033182:Intention; D008297:Male; D019300:Medical Errors / Q000517:prevention & control*; D008875:Middle Aged; D009042:Motivation; D009369:Neoplasms / Q000188:drug therapy* / Q000523:psychology*; D010349:Patient Compliance; D055815:Young Adult
D000970:Antineoplastic Agents